TrialEuropean journal of clinical pharmacology2013

Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia.

Francis J Giles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.